Germline DDX41 mutations define a significant entity within adult MDS/AML patients
M Sébert, M Passet, A Raimbault… - Blood, The Journal …, 2019 - ashpublications.org
Germline DDX41 mutations are involved in familial myelodysplastic syndromes (MDSs) and
acute myeloid leukemias (AMLs). We analyzed the prevalence and characteristics of DDX41 …
acute myeloid leukemias (AMLs). We analyzed the prevalence and characteristics of DDX41 …
The clinical spectrum, diagnosis, and management of GATA2 deficiency
M Santiago, A Liquori, E Such, Á Zúñiga, J Cervera - Cancers, 2023 - mdpi.com
Simple Summary A predisposition to myeloid neoplasms has recently been recognized as a
defined clinical entity by the World Health Organization. One of the most well-known …
defined clinical entity by the World Health Organization. One of the most well-known …
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
The inclusion of familial myeloid malignancies as a separate disease entity in the revised
WHO classification has renewed efforts to improve the recognition and management of this …
WHO classification has renewed efforts to improve the recognition and management of this …
AML through the prism of molecular genetics
S Charrot, H Armes, A Rio‐Machin… - British journal of …, 2020 - Wiley Online Library
Modern management of acute myeloid leukaemia (AML) relies on the integration of
phenotypic and genetic data to assign classification, establish prognosis, enhance …
phenotypic and genetic data to assign classification, establish prognosis, enhance …
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms
HB Alkhateeb, A Nanaa, D Viswanatha… - Blood …, 2022 - ashpublications.org
DDX41 mutations (germline and somatic) are associated with late onset myelodysplastic
syndromes/acute myeloid leukemia (MDS/AML). Myeloid neoplasms (MN) with germline …
syndromes/acute myeloid leukemia (MDS/AML). Myeloid neoplasms (MN) with germline …
[HTML][HTML] Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies
Purpose To determine the degree of testing consistency among commercially available
diagnostic assays for hereditary hematopoietic malignancies (HHMs). Methods Next …
diagnostic assays for hereditary hematopoietic malignancies (HHMs). Methods Next …
Diagnostic challenge and clinical dilemma: the long reach of clonal hematopoiesis
A Osman, JL Patel - Clinical Chemistry, 2021 - academic.oup.com
Background Widespread application of massively parallel sequencing has resulted in
recognition of clonal hematopoiesis in various clinical settings and on a relatively frequent …
recognition of clonal hematopoiesis in various clinical settings and on a relatively frequent …
Comparison between GATA2 and DDX41-mutated myeloid neoplasms
A Nanaa, R He, D Viswanatha… - Leukemia …, 2022 - pubmed.ncbi.nlm.nih.gov
Comparison between GATA2 and DDX41-mutated myeloid neoplasms Comparison between
GATA2 and DDX41-mutated myeloid neoplasms Leuk Res. 2022 Oct:121:106931. doi …
GATA2 and DDX41-mutated myeloid neoplasms Leuk Res. 2022 Oct:121:106931. doi …
Heterozygous loss of Srp72 in mice is not associated with major hematological phenotypes
T D'Altri, MB Schuster, A Wenzel… - European Journal of …, 2019 - Wiley Online Library
Objectives Familial cases of hematological malignancies are associated with germline
mutations. In particular, heterozygous mutations of SRP72 correlate with the development of …
mutations. In particular, heterozygous mutations of SRP72 correlate with the development of …
Evaluation of miR-143 rs4705342 and miR-222 rs2858060 genetic variants in patients with acute myeloid leukemia
R Mehrpour, L Kohan, MJ Mokhtari - Human Gene, 2022 - Elsevier
Background and aim Considering the importance of miR-143 and miR-222 in
carcinogenicity and the importance of miRSNPs in acute myeloid leukemia, this research …
carcinogenicity and the importance of miRSNPs in acute myeloid leukemia, this research …